Syndrome News and Research

RSS

Risk of death from SARS-CoV-2 infection higher than after COVID vaccination

Researchers investigate the risk of death following vaccination as compared to SARS-CoV-2 infection.

28 Mar 2022

Evaluating severity of influenza infection in ferrets with COVID-19 history

In a new study, researchers investigated the effect of SARS-CoV-2 exposure on the severity of influenza in ferrets.

28 Mar 2022

Examining differences in neurological manifestations induced by SARS-CoV-2 variants in hamsters

Researchers evaluated the neurological complications due to SARS-CoV-2 D614G strain, and variants of concern, Delta and Omicron in a hamster model.

28 Mar 2022

Dynamics of SARS-CoV-2 viral load in vaccinated and recovered individuals

A new study assessed the dynamics of viral load of SARS-CoV-2 Omicron and Delta variants of concern post-vaccination and previous infection.

28 Mar 2022

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

Researchers applied a previously developed thermostable self-amplifying ribonucleic acid vaccine to COVID-19.

28 Mar 2022

The potential risk of SARS-CoV-2 transmission through fomites contaminated by hospitalized COVID-19 patients

Researchers evaluated the potential risk of SARS-CoV-2 transmission through fomites contaminated by hospitalized COVID-19 patients during coughing or intense moistening with saliva.

28 Mar 2022

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

A recent study investigated the potency and functionality of T-cell and humoral responses against the SARS-CoV-2 wild-type strain and its variants.

28 Mar 2022

Study investigates recombinant SARS-CoV-2 variants in immunocompromised individuals

Researchers identified the recombination of two SARS-CoV-2 variants.

28 Mar 2022

Study estimates protection against reinfection following primary SARS-CoV-2 infection

A recent study investigated the protection provided by the primary SARS-CoV-2 infection against reinfection.

28 Mar 2022

Benefits of heterotypic vaccination against variants of SARS-CoV-2

A new study evaluated the antibody responses against the newly emerged SARS-CoV-2 Omicron variant upon heterotypic vaccination in animal models.

28 Mar 2022

Mathematical model of SARS-CoV-2 transmission tailored to the unique situation of China

Researchers designed a dynamic mathematical model to simulate the transmission of the SARS-CoV-2 Omicron variant in China and project its associated burden on healthcare facilities, should the zero-COVID-19 policy be lifted.

28 Mar 2022

Study evaluates receptor-binding domain antibodies for their ability to bind and neutralize Omicron

Researchers evaluated the ability of RBD antibodies to bind to and neutralize SARS-CoV-2 Omicron variant.

28 Mar 2022

Severe outcomes in hospitalized children during the Omicron BA.2-dominated fifth wave in Hong Kong

A recent study investigated the disease severity of SARS-CoV-2 Omicron BA.2 infection among Hong Kong children.

28 Mar 2022

Which U.S. cities are most vulnerable to spread of COVID-19?

Now, researchers from New Jersey City University have been attempting to explore the same factors to identify vulnerability in U.S. cities. Their research, under consideration at the journal Scientific Reports, is currently available on the Research Square* preprint server.

28 Mar 2022

Neutralization of BA.1 and BA.2 Omicron variants with monoclonal antibodies

A new research paper published as an early release manuscript in the Nature Medicine journal compares the sensitivity of this strain as well as the earlier Delta and the newer BA.2 to therapeutic mAbs.

27 Mar 2022

The effects of severe COVID-19 on the lungs after one year

While short-term lung damage has been reported in patients hospitalized with pneumonia caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is little data on the more chronic sequelae of this condition. A new research paper summarizes data from patients seen one year from discharge.

27 Mar 2022

Syndrome News and Research

Risk of death from SARS-CoV-2 infection higher than after COVID vaccination

Evaluating severity of influenza infection in ferrets with COVID-19 history

Examining differences in neurological manifestations induced by SARS-CoV-2 variants in hamsters

Dynamics of SARS-CoV-2 viral load in vaccinated and recovered individuals

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

The potential risk of SARS-CoV-2 transmission through fomites contaminated by hospitalized COVID-19 patients

Durability and functionality of the humoral and T-cell response to SARS-CoV-2 and its variants in recovered patients

Study investigates recombinant SARS-CoV-2 variants in immunocompromised individuals

Study estimates protection against reinfection following primary SARS-CoV-2 infection

Benefits of heterotypic vaccination against variants of SARS-CoV-2

Mathematical model of SARS-CoV-2 transmission tailored to the unique situation of China

Study evaluates receptor-binding domain antibodies for their ability to bind and neutralize Omicron

Severe outcomes in hospitalized children during the Omicron BA.2-dominated fifth wave in Hong Kong

Which U.S. cities are most vulnerable to spread of COVID-19?

Neutralization of BA.1 and BA.2 Omicron variants with monoclonal antibodies

The effects of severe COVID-19 on the lungs after one year

Tuberculosis infection protects mice against COVID-19

SARS-CoV-2 antibodies in breast milk remain after Holder pasteurization

CDK6: a potential drug target for severe COVID-19

Clinical determinants of post-COVID-19 thromboembolism

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News